07
Jul

Bristol-Myers Squibb has become the first drugmaker to win regulatory approval for a combination hepatitis C treatment that doesn’t require painful injections, picking up a Japanese nod for its all-oral cocktail.

…read more

Source: Bristol-Myers’ hep C combo wins Japanese OK, leading the pack

    

0 No comments